EVOLVE Study: The Real-life Clinical Practice With Tezepelumab in Greece
Clinical trial NCT06724575 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06724575
- Sponsor
- AstraZeneca
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-12-17
- Primary completion
- 2028-06-30
- Enrollment
- 155
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.